Hypertension and atrial fibrillation

Risk for Incident Atrial Fibrillation in Patients Who Receive Antihypertensive Drugs

(2013) Beat A. Schaer   ANNALS OF INTERNAL MEDICINE

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

(2011) John A. Cairns et al.   CANADIAN JOURNAL OF CARDIOLOGY

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)

(2011) L. Samuel Wann et al.   CIRCULATION

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2010) Isla M. Ogilvie et al.   AMERICAN JOURNAL OF MEDICINE

Validation of an Atrial Fibrillation Risk Algorithm in Whites and African Americans

(2010) Renate B. Schnabel et al.   ARCHIVES OF INTERNAL MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Birth Weight Is a Significant Risk Factor for Incident Atrial Fibrillation

(2010) David Conen et al.   CIRCULATION

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Age as a Risk Factor for Stroke in Atrial Fibrillation Patients

(2010) Ricarda Marinigh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition

(2010) Markus P. Schneider et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

(2010) Hans-Christoph Diener et al.   LANCET NEUROLOGY

Newly Identified Events in the RE-LY Trial

(2010) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines for the Primary Prevention of Stroke

(2010) Larry B. Goldstein et al.   STROKE

The RecordAF Study: Design, Baseline Data, and Profile of Patients According to Chosen Treatment Strategy for Atrial Fibrillation

(2009) Jean-Yves Le Heuzey et al.   AMERICAN JOURNAL OF CARDIOLOGY

Relationships of CRP and P Wave Dispersion With Atrial Fibrillation in Hypertensive Subjects

(2009) C. Tsioufis et al.   AMERICAN JOURNAL OF HYPERTENSION

Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis

(2009) Mhamad B Jibrini et al.   AMERICAN JOURNAL OF THERAPEUTICS

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

(2009) X. Du et al.   EUROPEAN HEART JOURNAL

A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure

(2009) Mamas A. Mamas et al.   EUROPEAN JOURNAL OF HEART FAILURE

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia

(2009) T. Jared Bunch et al.   HEART RHYTHM

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

(2009) Roland E Schmieder et al.   JOURNAL OF HYPERTENSION

Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study

(2009) Sebastiano Sciarretta et al.   JOURNAL OF HYPERTENSION

The Aging Process of the Heart: Obesity Is the Main Risk Factor for Left Atrial Enlargement During Aging

(2009) Jan Stritzke et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

(2009) L. Julian Haywood et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation

(2009) Stefan H. Hohnloser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Valsartan for Prevention of Recurrent Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey

(2008) M. Rivero-Ayerza et al.   EUROPEAN HEART JOURNAL

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

(2008) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE